Gregg W. Stone: Short-Term DOACs Show Advantage Over DAPT Post-LAAO
Gregg W. Stone, Interventional Cardiologist, Director of Academic Affairs for Mount Sinai Heart Health System, Professor of Medicine at Icahn School of Medicine, shared a post on X about a recent article he and his colleagues co-authored, published in EHJ, adding:
“Now published in EHJ:
In 3 RCTs (n=704), 2-3-mo Rx w/DOACs (low dose in 2 trials) low device-related thrombosis (DRT) and major bleeding c/w DAPT, with NS Δ in death and stroke/SE.
DRT has been associated with thromboembolic events, and the RR of 0.61 for stroke/SE favors DOAC use.”
Title: Direct oral anticoagulants vs dual antiplatelet therapy after left atrial appendage occlusion: a meta-analysis of trials
Authors: Ahmed Samy Badran, Gregg W. Stone
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 15:58Cristine Magallanes: Caring Beyond Hospitality – Accor Hosts Community Platelet Donation Drive
-
Oct 17, 2026, 15:57Isaac James: Zoster Vaccine Response in MPN Patients on JAK Inhibitors
-
Oct 17, 2026, 15:51Mohammad Reza Moghaddasnejad: A New Chapter in Cancer Research – Exploring the Role of Platelets in Cancer Metastasis
-
Oct 17, 2026, 15:44James P. Crowley: Drs. Blumberg and Heal Win SABM Sazama Award for Transfusion Research
-
Oct 17, 2026, 15:41X. Long Zheng։ ADAMTS13 and VWF in COVID-19-Associated Coagulopathy
-
Oct 17, 2026, 14:59Diwakar Mittal: From Dialogue to Action: Advancing Sickle Cell Disease Care in India
-
Oct 17, 2026, 12:21Jalen Hurts Sidelined by a Superficial Blood Clot: What to Know
-
Oct 17, 2026, 09:33Robert Lookstein: Mechanical Thrombectomy Shows Functional Benefits in Intermediate-High-Risk PE
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day